Recent IPSC Stock Price | IPSC Stock Predictions | |
$3.15 | +370.79% |
$14.83 |
Recent IPSC Analyst Ratings Breakdown, Making IPSC Stock Predictions | ||||
---|---|---|---|---|
Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | |
Strong buy ratings: | 6 | 6 | 6 | 6 |
Buy ratings: | 0 | 0 | 0 | 0 |
Hold ratings: | 1 | 1 | 1 | 1 |
Sell ratings: | 0 | 0 | 0 | 0 |
Strong sell ratings: | 0 | 0 | 0 | 0 |
Average rating: | 1.29 | 1.29 | 1.29 | 1.29 |
For the IPSC stock predictions from the analysts covering Century Therapeutics Inc, we have collected all of the individual IPSC stock predictions for stock price one year from now (i.e. each analyst's "forward price target") and at the top of this page we have presented the average prediction across the 6 different analysts covering IPSC (as reported in
data provided by Zacks Investment Research via Quandl.com).
But since IPSC stock predictions may vary widely, another useful metric to consider is the median IPSC stock prediction, which represents the price at which half of the analysts
made IPSC stock predictions that were higher and half made IPSC stock predictions that were lower. This makes for a different take on the IPSC stock predictions out there, as compared to average or mean.
And that median across all the individual IPSC stock predictions was: $13.5 as of 2024-04-26.
The very highest of the IPSC stock predictions for one year price target was $24.0, while the very lowest of the IPSC stock predictions in the analyst group was
$9.0 (with a standard deviation of $5.192). Get the latest Zacks research report on IPSC — FREE
Find out: IPSC next earnings date »
Dividend Growth Stocks: 25 Aristocrats
10 Dividend Bargains You Can Buy Cheaper Than Insiders Did
Other stock predictions:
RPM Stock Predictions
AMSWA Stock Predictions
DVN Stock Predictions
SPNS Stock Predictions
MIME Stock Predictions
IDN Stock Predictions
BAND Stock Predictions
CXP Stock Predictions
GGAL Stock Predictions
|
|
Strong Buy (3.71 out of 4) 71st percentile
(ranked higher than approx. 71% of all stocks covered)
Based on data provided by Zacks Investment Research via Quandl.com |